Custom Antibody Market by Type, Service, Source, Research Area, End Users, Application

List of Tables

The Global Custom Antibody Market is forecasted to grow significantly, with a projected USD 407.63 million in 2023 at a CAGR of 19.90% and expected to reach a staggering USD 1,497.58 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Custom Antibody Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Custom Antibody Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Monoclonal Antibodies commanded largest market share of 34.46% in 2022, followed by Polyclonal Antibodies.

Based on Service, market is studied across Antibody Development, Antibody Fragmentation & Labeling, and Antibody Production & Purification. The Antibody Development commanded largest market share of 31.34% in 2022, followed by Antibody Production & Purification.

Based on Source, market is studied across Mice and Rabbit. The Rabbit commanded largest market share of 34.56% in 2022, followed by Mice.

Based on Research Area, market is studied across Cardiovascular Diseases, Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem cells. The Oncology commanded largest market share of 21.45% in 2022, followed by Immunology.

Based on End Users, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies. The Pharmaceutical & Biotechnology Companies commanded largest market share of 47.34% in 2022, followed by Contract Research Organizations.

Based on Application, market is studied across Research and Therapeutics. The Research commanded largest market share of 61.46% in 2022, followed by Therapeutics.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 37.10% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Custom Antibody Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Custom Antibody Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Custom Antibody Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Custom Antibody Market?

4. What is the competitive strategic window for opportunities in the Global Custom Antibody Market?

5. What are the technology trends and regulatory frameworks in the Global Custom Antibody Market?

6. What is the market share of the leading vendors in the Global Custom Antibody Market?

7. What modes and strategic moves are considered suitable for entering the Global Custom Antibody Market?

Product Code: MRR-46132FF79AAC

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Custom Antibody Market, by Type, 2022 vs 2030
4.3. Custom Antibody Market, by Service, 2022 vs 2030
4.4. Custom Antibody Market, by Source, 2022 vs 2030
4.5. Custom Antibody Market, by Research Area, 2022 vs 2030
4.6. Custom Antibody Market, by End Users, 2022 vs 2030
4.7. Custom Antibody Market, by Application, 2022 vs 2030
4.8. Custom Antibody Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of chronic infectious disease across the globe
  - 5.1.1.2. Expanding applications of custom antibody across research, diagnostics, and therapeutics
  - 5.1.1.3. Soaring R&D activities and increasing awareness on personalized therapeutics
- 5.1.2. Restraints
  - 5.1.2.1. Requirements of huge time and extensive capital to develop custom antibodies
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing strategic investments in life science and biology sector by governments and private sectors
  - 5.1.3.2. Increase in therapeutics of antibodies and expansion of drug pipeline
- 5.1.4. Challenges
  - 5.1.4.1. Presence of alternative antibodies create fragmentation in the market
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Custom Antibody Market, by Type

6.1. Introduction
6.2. Monoclonal Antibodies
6.3. Polyclonal Antibodies
6.4. Recombinant Antibodies

7. Custom Antibody Market, by Service

7.1. Introduction
7.2. Antibody Development
7.3. Antibody Fragmentation & Labeling
7.4. Antibody Production & Purification

8. Custom Antibody Market, by Source

8.1. Introduction
8.2. Mice
8.3. Rabbit

9. Custom Antibody Market, by Research Area

9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Immunology
9.4. Infectious Diseases
9.5. Neurobiology
9.6. Oncology
9.7. Stem cells

10. Custom Antibody Market, by End Users

10.1. Introduction
10.2. Academic & Research Institutes
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharmaceutical & Biotechnology Companies

11. Custom Antibody Market, by Application

11.1. Introduction
11.2. Research
11.3. Therapeutics

12. Americas Custom Antibody Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Custom Antibody Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Custom Antibody Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

15. Competitive Landscape

15.1. FPNV Positioning Matrix
15.2. Market Share Analysis, By Key Player
15.3. Competitive Scenario Analysis, By Key Player
- 15.3.1. Merger & Acquisition
  - 15.3.1.1. LSBio Acquires Absolute Antibody Ltd.
  - 15.3.1.2. AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline
  - 15.3.1.3. KKR-backed Biosynth Carbosynth Acquires vivitide and Welcomes Ampersand Capital Partners as New Shareholder
- 15.3.2. Agreement, Collaboration, & Partnership
  - 15.3.2.1. Specifica Announces Antibody Discovery Platform Transfer Agreement with Servier and its Subsidiary Symphogen
  - 15.3.2.2. Celltrion and Genuv Partner to Develop Novel Therapeutic Antibodies
  - 15.3.2.3. AltaBioscience partners with Life Science Group for custom antibody production services
  - 15.3.2.4. Sino Biological and Ainnocence partner to offer next-generation antibody development CRO services
  - 15.3.2.5. Ligand signs merger agreement with Avista Public Acquisition
- 15.3.3. New Product Launch & Enhancement
  - 15.3.3.1. Absolute Biotech launches to offer worldwide antibody solutions
  - 15.3.3.2. Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates
- 15.3.4. Award, Recognition, & Expansion
  - 15.3.4.1. Ligand Announces that Janssen has Received Approval from European Commission for TECVAYLI (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

16. List of Company Mentioned

17. Appendix

17.1. Discussion Guide
17.2. License & Pricing

1. Abbiotec, Inc.

2. Abcam PLC

3. ABclonal, Inc.

4. Abgenex Pvt. Ltd.

5. Abimate Pharmaceutical (Shanghai) Co., Ltd.

6. Abnova Corporation

7. Acrobiosystems Inc.

8. Agilent Technologies, Inc.

9. Alta Bioscience Limited

10. Bio Basic Inc.

11. Bio-Rad Laboratories, Inc.

12. Bio-Techne Corporation

13. BioChain Incorporated

14. Bioklone Biotech Private Limited

15. BioLegend, Inc. by PerkinElmer, Inc.

16. Biosynth Ltd.

17. Boster Biological Technology

18. BTL Biotechno Labs Private Limited

19. Capralogics, Inc.

20. Cell Signaling Technology, Inc.

21. CiteAb Limited

22. Creative Biolabs

23. Creative Diagnostics

24. CSBio (Shanghai) Ltd.

25. Cusabio Technology LLC

26. Davids Biotechnologie GmbH

27. Elabscience

28. evitria AG

29. GenScript Biotech Corporation

30. Imgenex India Pvt. Ltd.

31. Innovagen AB

32. Inotiv, Inc.

33. Kaneka Eurogentec S.A.

34. Laboratory Corporation of America Holdings

35. Merck KGaA

36. Metabion International AG

37. MyBiosource, Inc.

38. OriGene Technologies, Inc.

39. Oy Medix Biochemica AB

40. Pacific Immunology

41. PhosphoSolutions

42. ProMab Biotechnologies, Inc.

43. ProSci Incorporated

44. ProteoGenix SA

45. RayBiotech Life, Inc.

46. Rockland Immunochemicals, Inc.

47. Sino Biological, Inc.

48. The Antibody Company

49. Thermo Fisher Scientific, Inc.

50. YenZym Antibodies, LLC